Top Section/Ad
Top Section/Ad
Most recent
Fluvius, Kojamo and Affinity Water hold investor calls
Sandwich chain joins host of ABS issuers
There is no crock of equity gold at the end of the rainbow
Partner has joined Clifford Chance from the newly merged rival magic circle law firm
More articles/Ad
More articles/Ad
More articles
-
BSN Medical, the German bandage maker, allocated the refinancing of its euro and dollar term loan 'Bs' late last week. The issuer achieved margins 75bp-100bp tighter than original guidance after attracting investor interest despite a quiet August in the leveraged loan market. -
The high yield market felt the August influence last week as trading was thin, no new primary deal plans dripped through and fund flows reduced to a minimum.
-
Bankers in Asia are expecting a pickup in loan activity, believing that corporates will realise that now is the time to tap the market for leveraged loans. While hopes are high for deals from more active markets such as Australia and China, bankers say India is worrisome owing to some recent regulatory changes.
-
European CMBS issuance is forecasted to reach €6.5bn this year — over double the €3.2bn in 2012 — but most outstanding loans are unlikely to be refinanced in the CMBS market, said Standard & Poor’s this week.
-
Richard Tynan has been appointed head of syndicate EMEA at RBS in London. He replaces Myles Clarke, who was named COO of RBS's new markets client board in July.
-
Boutique investment bank Exotix has hired Andreas Fessler to bolster its European team as it expands beyond its emerging market roots into traditional credit markets, writes Stefanie Linhardt.
